matchedPattern,context,lineNumber,columnNumber,publicationName
p.Leu1077Pro,...500-6-461Short ReportPhenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibr...,3,156,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro CFTR mutation was firstly described i...,4,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...tion collected in database CFTR2 lead to consider p.Leu1077Pro as a severe CF mutation. Although it ...,4,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...tation. Although it is typical of Southern Italy, p.Leu1077Pro is not included in the mutation panel...",4,272,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...atients. 4 patients who were heterozygous for the p.Leu1077Pro mutation were included in the study,7,106,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"In our Cystic Fibrosis Centre, the prevalence of p.Leu1077Pro is 3.6% among all mutations. All pati...",9,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,We found that the p.Leu1077Pro CFTR mutation is associated with a cl...,12,19,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...CFTR2 database. The relatively high prevalence of p.Leu1077Pro associated with the severe clinical c...,12,169,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro (L1077P) mutation consists in a trans...,21,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,... Bozon et al. [8] firstly found evidence that the p.Leu1077Pro was associated with a pancreatic suff...,23,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"... 40 patients with this mutation, lead to consider p.Leu1077Pro as a severe CF mutation, associated w...",25,119,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...it should be predictive of a severe CF phenotype, p.Leu1077Pro is not included in the mutation panel...",27,154,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...linical features in Sicilian patients bearing the p.Leu1077Pro CFTR mutation followed in our Cystic ...,29,114,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...range 7 – 20 years) who were heterozygous for the p.Leu1077Pro mutation were included in the study: ...,33,431,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,1	M	7 yrs	14.57 (Underweight)	Birth	p.Phe508del/p.Leu1077Pro	112	84/43,40,49,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,2	M	10	19.80 (Normal weight)	Birth	p.Phe508del/p.Leu1077Pro	101	155/215,41,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,3	M	12	19.63 (Normal weight)	Birth	p.Phe508del/p.Leu1077Pro	97	181/100,42,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,4	F	20	16.44 (Underweight)	4 months	p.Asn1303Lys/p.Leu1077Pro	108	NA,43,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...ing is routinely performed in our laboratory. The p.Leu1077Pro mutation was identified by denaturing...,62,541,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...icilian Cystic Fibrosis Centre, the prevalence of p.Leu1077Pro is 3.6% among all mutations",65,67,BMC_Res_Notes_2013_Nov_13_6_461.txt
